European Union has banned the marketing of around 700 generic medicines for alleged manipulation of clinical trials conducted by India’s pharmaceutical research company GVK Biosciences. The ban will come into effect on August 21. According to Germany’s drug regulator, the Federal Institute for Medicines and Medical Products and it will be applicable to all 28 member nations. GVK Bio had vehemently denied the allegations. The company offered to conduct fresh studies of the medicines involved at its own cost.
The Real Voice of India